Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Epidemiology/Health Services Research

Associations Between Diabetes and Both Cardiovascular Disease and All-Cause Mortality Are Modified by Grip Strength: Evidence From UK Biobank, a Prospective Population-Based Cohort Study

  1. Carlos A. Celis-Morales1,
  2. Fanny Petermann1,
  3. Li Hui1,
  4. Donald M. Lyall2,
  5. Stamatina Iliodromiti3,
  6. James McLaren1,
  7. Jana Anderson2,
  8. Paul Welsh1,
  9. Daniel F. Mackay2,
  10. Jill P. Pell2,
  11. Naveed Sattar1,
  12. Jason M.R. Gill1 and
  13. Stuart R. Gray1⇑
  1. 1Institute of Cardiovascular & Medical Sciences, University of Glasgow, Glasgow, U.K.
  2. 2Institute of Health & Wellbeing, University of Glasgow, Glasgow, U.K.
  3. 3School of Medicine, Dentistry & Nursing, University of Glasgow, Glasgow, U.K.
  1. Corresponding author: Stuart R. Gray, stuart.gray{at}glasgow.ac.uk.
Diabetes Care 2017 Dec; 40(12): 1710-1718. https://doi.org/10.2337/dc17-0921
PreviousNext
  • Article
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • Tables
  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    Association of all-cause mortality, CVD mortality, and CVD incidence by diabetes and grip strength strata. Individuals with diabetes and high grip strength were used as the reference group (Ref.). The model was adjusted for age; sex; ethnicity; deprivation index; professional qualifications; gross income; employment; month of recruitment; duration of diabetes; systolic blood pressure; baseline prevalence of hypertension; history of recent medication for diabetes (insulin), hypertension, and cholesterol; BMI categories; smoking; TV viewing; PC screen time; categories of sleep duration; physical activity; and dietary intake (alcohol, fruits and vegetables, red meat, processed meat, and oily fish).

Tables

  • Figures
  • Table 1

    Cohort characteristics by categories of handgrip strength and diagnosed diabetes

    Without diabetesWith diabetes
    Sociodemographic characteristicOverallLow strengthMiddle strengthHigh strengthLow strengthMiddle strengthHigh strength
    Total participants347,13060,979136,679136,0993,7495,3674,257
    Women188,171 (54.2)33,043 (54.2)75,350 (55.1)74,562 (54.8)1,410 (37.6)2,030 (37.8)1,776 (41.7)
    Age (years)55.9 (8.1)55.9 (8.0)56.0 (8.1)55.4 (8.2)59.1 (7.2)59.4 (7.2)58.8 (7.2)
    Deprivation index quintiles
     Low120,852 (34.8)18,352 (30.1)47,745 (35.0)51,088 (37.5)810 (21.6)1,501 (28.0)1,356 (31.9)
     Middle118,416 (34.1)19,981 (32.8)46,921 (34.3)47,215 (34.7)1,112 (29.7)1,743 (32.5)1,444 (33.9)
     High107,862 (31.1)22,646 (37.1)42,013 (30.7)37,796 (27.8)1,827 (48.7)2,123 (39.5)1,457 (34.2)
    Professional qualification
     College or university degree118,754 (40.4)18,999 (38.5)46,573 (40.3)49,682 (41.9)908 (34.1)1,397 (34.0)1,195 (35.6)
     A/AS levels or equivalent39,908 (13.6)6,714 (13.6)15,572 (13.5)16,313 (13.7)339 (12.7)567 (13.8)403 (12.0)
     O level/GCSE or equivalent75,581 (25.7)13,054 (26.4)30,301 (26.2)29,464 (24.8)718 (27.0)1,144 (27.9)900 (26.8)
     CSE or equivalent20,044 (6.8)3,926 (7.9)7,919 (6.9)7,531 (6.3)210 (7.8)251 (6.1)207 (6.1)
     NVQ or HND or HNC or equivalent22,247 (7.6)3,778 (7.6)8,543 (7.4)8,821 (7.4)268 (10.1)438 (10.7)399 (11.9)
     Other professional qualification17,424 (5.9)2,980 (6.0)6,691 (5.7)6,969 (5.9)221 (8.3)307 (7.5)256 (7.6)
    Income
     <£18,00057,816 (19.2)12,637 (24.4)22,813 (19.2)18,798 (15.7)1,268 (40.6)1,377 (30.3)923 (25.3)
     £18,000–51,999157,608 (52.2)26,720 (51.7)62,401 (52.5)62,778 (52.4)1,434 (45.9)2,342 (51.6)1,933 (53.0)
     >£52,00086,251 (28.6)12,378 (23.9)33,623 (28.3)38,209 (31.9)425 (13.5)824 (18.1)792 (21.7)
    Employment status
     Paid or self-employed216,635 (62.9)36,259 (60.1)85,494 (63.1)88,582 (65.5)1,579 (42.8)2,502 (47.1)2,219 (52.5)
     Retired104,497 (30.4)18,457 (30.6)41,648 (30.7)38,746 (28.7)1,556 (42.4)2,385 (44.8)1,705 (40.4)
     Looking after home and/or family9,845 (2.9)1,728 (2.9)3,797 (2.8)4,026 (3.0)99 (2.6)106 (2.0)89 (2.1)
     Unable to work because of sickness or disability5,269 (1.5)2,067 (3.4)1,537 (1.1)1,094 (0.8)296 (8.0)177 (3.3)98 (2.3)
     Unemployed5,498 (1.6)1,339 (2.2)2,140 (1.6)1,683 (1.3)132 (3.6)116 (2.2)88 (2.1)
     Unpaid or voluntary work1,568 (0.5)278 (0.5)591 (0.4)642 (0.5)15 (0.4)22 (0.4)20 (0.5)
     Full- or part-time student929 (0.2)183 (0.3)336 (0.3)382 (0.2)10 (0.2)11 (0.2)7 (0.1)
    Race/ethnicity
     White328,088 (94.5)55,634 (91.2)130,014 (95.2)130,896 (96.2)2,955 (78.8)4,719 (87.9)3,870 (90.9)
     South Asian6,601 (1.9)2,602 (4.3)2,245 (1.6)870 (0.6)478 (12.8)309 (5.8)98 (2.3)
     Black5,930 (1.7)1,084 (1.8)1,938 (1.4)2,355 (1.7)160 (4.3)194 (3.6)199 (4.7)
     Chinese1,221 (0.4)373 (0.6)512 (0.4)275 (0.2)24 (0.6)25 (0.5)12 (0.3)
     Mixed background/other5,290 (1.5)1,287 (2.1)1,970 (1.4)1,703 (1.3)132 (3.5)120 (2.2)78 (1.8)
    Smoking status
     Never198,235 (57.1)36,187 (59.3)79,118 (57.9)76,381 (56.1)1,942 (51.8)2,659 (49.5)1,948 (45.8)
     Former115,472 (33.3)18,597 (30.5)44,707 (32.7)46,654 (34.3)1,429 (38.1)2,205 (41.1)1,880 (44.2)
     Current33,423 (9.6)6,195 (10.2)12,854 (9.4)13,064 (9.6)378 (10.1)503 (9.4)429 (10.0)
    Obesity-related markers
     BMI (kg/m2)27.2 (4.6)27.1 (4.7)26.8 (4.4)27.1 (4.4)31.1 (6.0)31.0 (5.7)31.2 (5.6)
     BMI category
      Underweight (<18.5 kg/m2)1,659 (0.5)448 (0.7)754 (0.5)439 (0.3)11 (0.3)4 (0.1)3 (0.1)
      Normal weight (18.5–24.9 kg/m2)118,469 (34.1)21,219 (34.8)49,991 (36.6)45,661 (33.6)485 (12.9)653 (12.2)460 (10.8)
      Overweight (25.0 to 29.9 kg/m2)148,864 (42.9)25,418 (41.7)58,380 (42.7)60,315 (44.3)1,319 (35.2)1,912 (35.6)1,520 (35.7)
      Obese (≥30.0 kg/m2)78,138 (22.5)13,894 (22.8)27,554 (20.2)29,684 (21.8)1,934 (51.6)2,798 (52.1)2,274 (53.4)
     Waist circumference (cm)89.6 (13.1)89.6 (13.1)88.6 (12.8)89.3 (12.8)102.5 (14.5)101.8 (14.2)101.6 (14.1)
     Central obesity108,502 (31.3)19,575 (32.1)39,323 (28.8)41,112 (30.2)2,401 (64.1)3,355 (62.5)2,736 (64.3)
     Body fat (%)31.0 (8.5)31.5 (8.6)30.9 (8.4)30.6 (8.4)33.8 (8.6)33.4 (8.5)33.4 (8.6)
    Fitness, physical activity, and sleep
     Grip strength (kg)31.2 (11.0)21.3 (7.6)29.2 (8.3)37.7 (10.5)22.0 (7.4)30.9 (8.0)38.9 (10.1)
     Total physical activity (MET-h/week)6.6 (9.1)5.9 (8.8)6.5 (9.0)7.0 (9.3)4.9 (8.4)5.6 (8.0)6.2 (8.9)
     TV viewing (h/day)2.7 (1.6)2.8 (1.7)2.7 (1.5)2.6 (1.5)3.5 (2.0)3.3 (1.8)3.2 (1.7)
     PC screen time (h/day)1.2 (1.3)1.2 (1.4)1.2 (1.3)1.2 (1.3)1.3 (1.6)1.3 (1.6)1.3 (1.4)
     Sleep time category
      Normal (7–9 h)259,008 (74.9)43,542 (71.8)102,490 (75.2)103,643 (76.3)2,480 (66.7)3,786 (70.9)3,067 (72.3)
      Short sleepers (<7 h)82,776 (23.9)16,059 (26.5)32,219 (23.7)30,901 (22.8)1,108 (29.8)1,410 (26.4)1,079 (25.5)
      Long sleepers (>9 h)4,190 (1.2)1,035 (1.7)1,542 (1.1)1,239 (0.9)132 (3.5)148 (2.7)94 (2.2)
    Dietary intake
     TE (kcal/day)2,118 (645)2,097 (666)2,109 (636)2,136 (641)2,080 (731)2,093 (684)2,128 (686)
     Protein (% of TE)15.5 (3.6)15.5 (3.7)15.5 (3.6)15.6 (3.6)16.2 (4.2)16.2 (4.0)16.4 (3.7)
     Carbohydrates (% of TE)47.2 (8.1)47.7 (8.4)47.2 (8.1)46.9 (8.0)47.0 (8.8)46.4 (8.3)45.9 (8.3)
     Total fat (% of TE)32.0 (6.7)31.9 (6.8)32.0 (6.7)32.1 (6.6)32.7 (7.2)32.4 (7.0)32.8 (7.0)
     Saturated fat (% of TE)12.3 (3.3)12.2 (3.4)12.2 (3.3)12.3 (3.3)12.4 (3.6)12.4 (3.5)12.4 (3.4)
     Sugar (% of TE)22.5 (7.0)22.7 (7.3)22.5 (6.9)22.5 (6.8)20.4 (7.4)20.2 (6.8)20.0 (6.7)
     Alcohol (% of TE)5.3 (6.5)4.9 (6.5)5.3 (6.5)5.4 (6.4)4.1 (6.7)4.9 (7.1)4.9 (6.9)
     Red meat (portions/week)1.9 (1.4)1.9 (1.4)1.9 (1.4)1.9 (1.4)2.1 (1.7)2.1 (1.6)2.1 (1.5)
     Processed meat (portions/week)1.9 (1.1)1.9 (1.1)1.9 (1.1)1.9 (1.0)2.0 (1.1)2.0 (1.1)2.0 (1.0)
     Fruits and vegetables (g/day)330.4 (192.0)322.9 (201.9)327.3 (189.0)334.5 (188.5)346.8 (201.0)352.3 (204.5)361.8 (214.8)
     Oily fish (portions/week)1.1 (1.0)1.1 (1.0)1.1 (1.0)1.1 (1.0)1.1 (1.2)1.2 (1.1)1.2 (1.1)
    Health status
     Duration of diabetes (years)0.2 (1.6)0006.7 (6.4)6.0 (5.8)5.5 (5.7)
     Systolic blood pressure (mmHg)139.7 (19.6)138,1 (19.6)139.2 (19.7)140.5 (19.5)142.8 (18.6)144.3 (18.1)145.3 (17.9)
     Diastolic blood pressure (mmHg)82.5 (10.7)81.7 (10.8)82.2 (10.7)83.0 (10.6)81.6 (10.0)82.5 (9.9)83.4 (10.0)
     High blood pressure history79,937 (23.0)14,243 (23.4)29,264 (21.4)28,573 (21.0)2,224 (59.3)3,178 (59.2)2,455 (57.7)
    Medication for cholesterol or blood pressure
     None310,655 (89.5)54,200 (88.9)123,477 (90.3)123,690 (90.9)2,614 (69.7)3,761 (70.1)2,913 (68.4)
     Cholesterol18,119 (5.2)3,184 (5.2)5,977 (4.4)5,461 (4.0)963 (25.7)1,393 (26.0)1,141 (26.8)
     Insulin117 (0.04)00051 (1.2)39 (0.7)27 (0.7)
     Blood pressure 18,356 (5.3)3,595 (5.9)7,225 (5.3)6,948 (5.1)172 (4.6)213 (3.9)203 (4.8)
    • Data are n (%) for categorical variables or mean (SD) for continuous variables. Data were available for 210,064 participants. A/AS, advanced; CSE, Certificate of Secondary Education; GCSE, General Certificate of Secondary Education; HNC, Higher National Certificate; HND, Higher National Diploma; NVQ, National Vocational Qualification; O, ordinary; TE, total energy.

  • Table 2

    Cox proportional hazards models for all-cause mortality and CVD incidence and mortality in participants with diabetes

    Total participants, nDeaths/events, nHR (95% CI)P value
    All-cause mortality
     Model 0347,1306,2091.72 (1.58, 1.88)<0.0001
     Model 1347,1306,2091.65 (1.51, 1.81)<0.0001
     Model 2347,1306,2091.55 (1.42, 1.70)<0.0001
    CVD mortality
     Model 0347,1305942.19 (1.71, 2.80)<0.0001
     Model 1347,1305942.07 (1.61, 2.67)<0.0001
     Model 2347,1305941.95 (1.50, 2.52)<0.0001
    CVD incidence
     Model 0347,1304,3011.44 (1.29, 1.61)<0.0001
     Model 1347,1304,3011.36 (1.21, 1.52)<0.0001
     Model 2347,1304,3011.22 (1.09, 1.37)0.001
    Circulatory mortality
     Model 0347,1301,8112.49 (2.17, 2.85)<0.0001
     Model 1347,1301,8112.22 (1.93, 2.55)<0.0001
     Model 2347,1301,8112.00 (1.74, 2.31)<0.0001
    Circulatory incidence
     Model 0347,13019,1301.50 (1.42, 1.58)<0.0001
     Model 1347,13019,1301.34 (1.27, 1.42)<0.0001
     Model 2347,13019,1301.22 (1.16, 1.29)<0.0001
    • People without diabetes were used as the reference category. Participants who were diagnosed with diabetes before age 30 years were removed from the analysis. All analyses were performed as a landmark analysis, with follow-up commencing 2 years after recruitment and including participants who were event free at that time. In addition, participants with comorbidities at baseline (depression, COPD, chronic asthma, chronic liver disease, alcohol problems, substance abuse, eating disorders, schizophrenia, cognitive impairment, Parkinson disease, dementia, chronic pain syndrome, heart disease, inflammatory disease, arthrosis, arthritis, and cancer [n = 103,755]) were excluded from all analyses. Model 0 was adjusted for age, sex, ethnicity, deprivation index, professional qualifications, gross income, employment, and month of recruitment. Model 1 was adjusted for duration of diabetes, systolic blood pressure, baseline prevalence of hypertension, and history of recent medication for diabetes (insulin), hypertension, and cholesterol. Model 2 was adjusted for model 1 plus BMI categories, smoking, TV viewing, PC screen time, categories of sleep duration, and dietary intake (alcohol, fruits and vegetables, red meat, processed meat, and oily fish).

  • Table 3

    Cox proportional hazards models for all-cause mortality and CVD incidence and mortality in participants with diabetes by grip strength category

    Age- and sex-specific grip strength category, HR (95% CI)P value
    Total, nDeaths/events, nHigherMiddleLowerTrendTrendInteraction
    All-cause mortality
     Model 0
      Without diabetes333,7575,6401.00 (Ref)1.22 (1.15, 1.29)1.69 (1.57, 1.81)1.29 (1.25, 1.34)<0.00010.009
      With diabetes13,3735691.00 (Ref)1.29 (1.05, 1.59)2.04 (1.65, 2.53)1.44 (1.29, 1.60)<0.0001
     Model 1
      Without diabetes333,7575,6401.00 (Ref)1.23 (1.16, 1.30)1.70 (1.59, 1.83)1.30 (1.25, 1.34)<0.00010.010
      With diabetes13,3735691.00 (Ref)1.32 (1.07, 1.62)2.10 (1.70, 2.61)1.46 (1.31, 1.63)<0.0001
     Model 2
      Without diabetes333,7575,6401.00 (Ref)1.23 (1.16, 1.30)1.70 (1.58, 1.82)1.30 (1.25, 1.34)<0.00010.020
      With diabetes13,3735691.00 (Ref)1.34 (1.09, 1.66)2.05 (1.65, 2.54)1.44 (1.29, 1.60)<0.0001
    CVD mortality
     Model 0
      Without diabetes333,7575191.00 (Ref)1.27 (1.04, 1.55)1.71 (1.36, 2.16)1.30 (1.16, 1.47)<0.00010.019
      With diabetes13,373751.00 (Ref)1.52 (0.82, 2.81)2.62 (1.42, 4.81)1.63 (1.20, 2.21)0.002
     Model 1
      Without diabetes333,7575191.00 (Ref)1.30 (1.07, 1.58)1.78 (1.41, 2.25)1.33 (1.18, 1.49)<0.00010.017
      With diabetes13,373751.00 (Ref)1.61 (0.87, 2.99)2.83 (1.53, 5.21)1.69 (1.25, 2.29)0.001
     Model 2
      Without diabetes333,7575191.00 (Ref)1.30 (1.07, 1.59)1.78 (1.40, 2.25)1.33 (1.18, 1.49)<0.00010.016
      With diabetes13,373751.00 (Ref)1.69 (0.91, 3.13)2.88 (1.55, 5.35)1.70 (1.25, 2.30)0.001
    CVD incidence
     Model 0
      Without diabetes333,7573,9661.00 (Ref)1.20 (1.12, 1.29)1.45 (1.33, 1.58)1.20 (1.15, 1.26)<0.00010.042
      With diabetes13,3733351.00 (Ref)1.08 (0.82, 1.42)1.87 (1.43, 2.46)1.39 (1.20, 1.60)<0.0001
     Model 1
      Without diabetes333,7573,9661.00 (Ref)1.23 (1.15, 1.32)1.51 (1.39, 1.65)1.23 (1.18, 1.28)<0.00010.037
      With diabetes13,3733351.00 (Ref)1.12 (0.85, 1.47)1.98 (1.50, 2.59)1.42 (1.24, 1.64)<0.0001
     Model 2
      Without diabetes333,7573,9661.00 (Ref)1.23 (1.14, 1.32)1.49 (1.36, 1.62)1.22 (1.17, 1.27)<0.00010.041
      With diabetes13,3733351.00 (Ref)1.14 (0.87, 1.50)1.98 (1.50, 2.60)1.42 (1.23, 1.64)<0.0001
    • People in the highest category for grip strength were used as the reference (Ref) category. Participants who were diagnosed with diabetes before the age of 30 years were removed from the analysis. All analyses were performed as a landmark analysis, with follow-up commencing 2 years after recruitment and including participants who were event free at that time. In addition, participants with comorbidities at baseline (depression, COPD, chronic asthma, chronic liver disease, alcohol problems, substance abuse, eating disorders, schizophrenia, cognitive impairment, Parkinson disease, dementia, chronic pain syndrome, heart disease, inflammatory disease, arthrosis, arthritis, CVD, and cancer [n = 103,755]) were excluded from all analyses. Model 0 was adjusted for age, sex, ethnicity, deprivation index, professional qualifications, gross income, employment, and month of recruitment. Model 1 was adjusted for duration of diabetes, systolic blood pressure, baseline prevalence of hypertension, and history of recent medication for diabetes (insulin), hypertension, and cholesterol. Model 2 was adjusted for model 1 plus BMI category, smoking, TV viewing, PC screen time, category of sleep duration, physical activity, and dietary intake (alcohol, fruits and vegetables, red meat, processed meat, and oily fish).

PreviousNext
Back to top
Diabetes Care: 40 (12)

In this Issue

December 2017, 40(12)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Associations Between Diabetes and Both Cardiovascular Disease and All-Cause Mortality Are Modified by Grip Strength: Evidence From UK Biobank, a Prospective Population-Based Cohort Study
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Associations Between Diabetes and Both Cardiovascular Disease and All-Cause Mortality Are Modified by Grip Strength: Evidence From UK Biobank, a Prospective Population-Based Cohort Study
Carlos A. Celis-Morales, Fanny Petermann, Li Hui, Donald M. Lyall, Stamatina Iliodromiti, James McLaren, Jana Anderson, Paul Welsh, Daniel F. Mackay, Jill P. Pell, Naveed Sattar, Jason M.R. Gill, Stuart R. Gray
Diabetes Care Dec 2017, 40 (12) 1710-1718; DOI: 10.2337/dc17-0921

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Associations Between Diabetes and Both Cardiovascular Disease and All-Cause Mortality Are Modified by Grip Strength: Evidence From UK Biobank, a Prospective Population-Based Cohort Study
Carlos A. Celis-Morales, Fanny Petermann, Li Hui, Donald M. Lyall, Stamatina Iliodromiti, James McLaren, Jana Anderson, Paul Welsh, Daniel F. Mackay, Jill P. Pell, Naveed Sattar, Jason M.R. Gill, Stuart R. Gray
Diabetes Care Dec 2017, 40 (12) 1710-1718; DOI: 10.2337/dc17-0921
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Research Design and Methods
    • Results
    • Conclusions
    • Article Information
    • Footnotes
    • References
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Postintervention Effects of Varying Treatment Arms on Glycemic Failure and β-Cell Function in the TODAY Trial
  • Worldwide Epidemiology of Diabetes-Related End-Stage Renal Disease, 2000–2015
  • Incident Type 2 Diabetes and Risk of Fracture: A Comparative Cohort Analysis Using U.K. Primary Care Records
Show more Epidemiology/Health Services Research

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.